Panagiotis Kousidis

Dr. Panagiotis Kousidis

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
Konstantinos TigkiropoulosKonstantinos Tigkiropoulos
Konstantinos Tigkiropoulos
IPIoakeim Papoutsis
Ioakeim Papoutsis
MAManolis Abatzis-Papadopoulos
Manolis Abatzis-Papadopoulos
PKPanagiotis Kousidis
Panagiotis Kousidis
DMDimitrios Mpismpos
Dimitrios Mpismpos
NSNikolaos Saratzis
Nikolaos Saratzis
Objective: The aim of this study was to provide early-term evaluation, safety, and efficacy of the novel CGuard (Inspire MD, Tel Aviv, Israel) micromesh self-expanding stent with embolic protection system (EPS) during carotid artery stenting (CAS) procedure. Materials and Methods: All patients who underwent CAS with CGuard carotid stent system from January 2018 to September 2020 in a tertiary center were prospectively evaluated. Primary endpoints included technical success and perioperative neurological events (0–48 hours). Secondary endpoint was the rate of neurologic, cardiac events, and death (major adverse event or MAE) at 30 days. Patency of CGuard, peak systolic velocity (PSV), and end diastolic velocity (EDV) were evaluated at 30 days with duplex ultrasound. Results: A total of 103 patients underwent CAS procedure. Forty patients were symptomatic, and 63 patients were asymptomatic with stenosis greater than 70%. Technical success was 100%. Local anesthesia was applied in 94 patients (93%). Embolic protection devices were used in 6 patients (5.8%). Access site complications were 1.9%. Mean internal carotid artery stenosis diameter reduced from 79.47% to 14.68%. Two patients had transient ischemic attack (1.9%) and 1 patient experienced a cerebral hyperperfusion syndrome (CHS) perioperatively. External carotid artery (ECA) occlusion occurred in 1.9%. Four patients experienced jaw claudication (3.8%) postoperatively. Mean time of operation was 41 minutes. Mean duration of hospitalization was 3.1 days. The 30-day rate of MAE was 0%. CGuard patency was 100%, mean internal carotid PSV was reduced from 251.57 to 77.29 cm/s, and mean internal carotid EDV was reduced from 154.62 to 24.63 cm/s at 30 days. Conclusion: Our study shows that CGuard stent with EPS is an effective and safe device for treatment of carotid artery stenosis with acceptable low perioperative neurologic events, even with low embolic protection device usage. Larger multicenter and randomized studies are necessary to confirm its long-term efficacy.

28 July 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
VTVasileios Theocharidis
Vasileios Theocharidis
TRThomas Rallis
Thomas Rallis
AGApostolos Stefanos Gogakos
Apostolos Stefanos Gogakos
DPDimitrios Paliouras
Dimitrios Paliouras
ALAchilleas Lazopoulos
Achilleas Lazopoulos
NBNikolaos Barbetakis
Nikolaos Barbetakis
Malignant mediastinal tumors are a group representing some of the most demanding oncological challenges for early, multi-level, and successful management. The timely identification of any suspicious clinical symptomatology is urgent in achieving an accurate, staged histological diagnosis, in order to follow up with an equally detailed medical therapeutic plan (interventional or not) and determine the principal goals regarding efficient overall treatment in these patients. We report a case of a 24-year-old male patient with an incident-free prior medical history. An initial chest X-ray was performed after the patient reported short-term, consistent moderate chest pain symptomatology, early work fatigue, and shortness of breath. The following imaging procedures (chest CT, PET-CT) indicated the presence of an anterior mediastinal mass (meas. ~11 cm × 10 cm × 13 cm, SUV: 8.7), applying additional pressure upon both right heart chambers. The Alpha-Fetoprotein (aFP) blood levels had exceeded at least 50 times their normal range. Two consecutive diagnostic attempts with non-specific histological results, a negative-for-malignancy fine-needle aspiration biopsy (FNA-biopsy), and an additional tumor biopsy, performed via mini anterior (R) thoracotomy with “suspicious” cellular gatherings, were performed elsewhere. After admission to our department, an (R) Video-Assisted Thoracic Surgery (VATS) was performed, along with multiple tumor biopsies and moderate pleural effusion drainage. The tumor’s measurements had increased to DMax: 16 cm × 9 cm × 13 cm, with a severe degree of atelectasis of the Right Lower Lobe parenchyma (RLL) and a pressure-displacement effect upon the Superior Vena Cava (SVC) and the (R) heart sinus, based on data from the preoperative chest MRA. The histological report indicated elements of a combined, non-seminomatous germ-cell mediastinal tumor, posthuberal-type teratoma, and embryonal carcinoma. The imminent chemotherapeutic plan included a “BEP” (Bleomycin®/Cisplatin®/Etoposide®) scheme, which needed to be modified to a “VIP” (Cisplatin®/Etoposide®/Ifosfamide®) scheme, due to an acute pulmonary embolism incident. While the aFP blood levels declined, even reaching normal measurements, the tumor’s size continued to increase significantly (DMax: 28 cm × 25 cm × 13 cm), with severe localized pressure effects, rapid weight loss, and a progressively worsening clinical status. Thus, an emergency surgical intervention took place via median sternotomy, extended with a complementary “T-Shaped” mini anterior (R) thoracotomy. A large, approx. 4 Kg mediastinal tumor was extracted, with additional RML and RUL “en-bloc” segmentectomy and partial mediastinal pleura decortication. The following histological results, apart from verifying the already-known posthuberal-type teratoma, indicated additional scattered small lesions of combined high-grade rabdomyosarcoma, chondrosarcoma, and osteosarcoma, as well as numerous high-grade glioblastoma cellular gatherings. No visible findings of the previously discovered non-seminomatous germ-cell and embryonal carcinoma elements were found. The patient’s postoperative status progressively improved, allowing therapeutic management to continue with six “TIP” (Cisplatin®/Paclitaxel®/Ifosfamide®) sessions, currently under his regular “follow-up” from the oncological team. This report underlines the importance of early, accurate histological identification, combined with any necessary surgical intervention, diagnostic or therapeutic, as well as the appliance of any subsequent multimodality management plan. The diversity of mediastinal tumors, especially for young patients, leaves no place for complacency. Such rare examples may manifest, with equivalent, unpredictable evolution, obliging clinical physicians to stay constantly alert and not take anything for granted.

20 January 2025 in Cureus
Verified
Journal Article
Open access
PKPanagiotis Kousidis
Panagiotis Kousidis
NBNikolaos Barbetakis
Nikolaos Barbetakis
DPDemetrios Paliouras
Demetrios Paliouras
DMDespoina Masmanidou
Despoina Masmanidou
ANAnastasia Nikolaidou
Anastasia Nikolaidou
Pathologists or laboratory technicians who perform a gross examination of lung specimens may, under the pressure of performing a frozen section or in a less urgent setting when selecting permanent sections, encounter a specimen with a lesion close to a stapled surgical margin. Performing a perpendicular section from the lesion to the closest surgical margin is often necessary, and the technique of shaving the staple line from the specimen before sectioning may yield suboptimal results in margin assessment. It is widely accepted that staple removal is a tedious task, both time-consuming and, more importantly, with a high risk of damaging the stapled tissue and causing difficulty in its precise microscopic evaluation. With regard to three-dimensional (3D) printing, the emergence of software for 3D design, with easy-to-learn interfaces, available at no monetary cost, as well as the ability to have one's designs produced and delivered swiftly and at low cost through regional stores, has bridged the gap between conception and implementation of novel ideas in several sectors of medicine. A grossing tool was designed and 3D printed, with the aim of facilitating the procedure of staple removal by reducing the time required and the tissue damage caused. The tool was tested on test material created from synthetic sponges, with the goal of simulating the physical properties of lung parenchyma. The variables measured were time for removal per staple and estimated test material damage after removal of each staple. Two techniques for staple removal were used: the "pinch-and-pull" technique of vertically pulling the staple and the "push-through" technique of carefully lifting the staple by pushing the forceps perpendicularly underneath the staple. The results showed that the use of the tool is superior, with improvement for both variables in both techniques. Our report aims to showcase this novel grossing tool, present the approach to its creation, analyze relevant medical literature, and also highlight the ease of implementation and future prospects of 3D printed designs in medical education and practice.

18 June 2026 in Cureus
Verified
Journal Article
Open access
PKPanagiotis Kousidis
Panagiotis Kousidis
ASAntonia Syrnioti
Antonia Syrnioti
FPFoteini Pavlidou
Foteini Pavlidou
MPMiltiadis Pliachas
Miltiadis Pliachas
ANAnastasia Nikolaidou
Anastasia Nikolaidou
Accurate gross examination of mastectomy specimens relies on accurate correlation between preoperative imaging and specimen anatomy to guide sectioning, orientation, and margin-oriented sampling. Radiologic-pathologic spatial discordance remains a common source of variability, particularly in multifocal tumors and in neoadjuvant-treated specimens with poorly defined tumor beds. Three-dimensional (3D) printing enables the production of patient-specific physical models that may assist in tumor localization and spatial understanding during macroscopic assessment. In this proof-of-concept study, two representative breast magnetic resonance imaging (MRI) examinations were selected from the DUKE-BREAST-CANCER-MRI dataset of The Cancer Imaging Archive (TCIA). The two cases represented unifocal and multifocal breast cancer, respectively. Segmentation of the breast contour and lesions identified as tumors was performed in both cases, with additional segmentation of a possible enlarged axillary lymph node in the second case. Anatomical orientation labels, a nipple landmark, and empty rectangular labels for each case number were incorporated into both models. The projection of the lesions onto the anterior external breast contour was encoded using protruding lines to indicate their relative surface extent. Each model was printed in separate parts, sectioned along the sagittal plane, to indicate the relative position of the tumor(s) in sagittal cross-section. All models were printed using polylactic acid (PLA) filament on a Bambu Lab A1 3D printer (Bambu Lab, Shenzhen, People's Republic of China). Printing time and material use were recorded at the maximal print speed preset of 166%. A Pareto analysis, on printer-estimated total print time and slicer-estimated total material use, was performed on the two-tumor model, with identification of the respective Pareto knees. An additional third model was produced from an MRI examination showing a lesion with associated breast skin thickening and enhancement. This model was printed in two colors to aid the identification of the extent of breast skin with MRI abnormalities. For all three models, a cost estimation was performed, incorporating material use, electricity consumption, and final print weight after support removal for the estimation of incineration cost. In conclusion, MRI-derived, patient-specific 3D-printed breast models may be produced in modest time and at low cost within a pathology-oriented workflow. They may be used not only for spatial orientation but also for educational and research purposes. This proof-of-concept study supports further evaluation of such models as spatial orientation aids for gross sectioning, tumor bed localization, and margin-oriented sampling, particularly in cases with radiologic-pathologic discordance and in neoadjuvant-treated specimens. Future clinical decision support applications would require the development of a validated workflow for model production.